Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ChiCTR2100048747Phase 4Not yet recruiting
Phase 4, randomised trial of sufentanil in strabismus (3 arms), sponsored by Tongji Hospital. Primary endpoints: Intraoperative vital signs and Intraoperative complications and medication. Planned start Aug 2021; status: not yet recruiting.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on ChiCTR2100048747.